[Pharmacotherapeutical management of bronchial asthma]. 1998

S L Leont'ev, and V G Mikhaĭlov, and V P Nevzorova, and R V Sadovnikova, and A F Shabashov, and T K Lugovkina, and I V Leshchenko, and E K Bel'tiukov, and M K Lebedeva

The analysis of the prescriptions for bronchial asthma (BA) patients in outpatient practice was made using data base created at the Regional Fund of Obligatory Health Insurance in the Sverdlovsk region with consideration of GINA principles of BA stepped care. The real structure of prescriptions was compared with the pattern drug official list for asthma care. The cost of each BA care step was calculated on the base of the computer programs. The analysis showed low quality of BA care in outpatient practice. The created computer programs are very useful for the prescriptions structure monitoring, cost-effect analysis and pharmacotherapeutical management of the diseases.

UI MeSH Term Description Entries
D007356 Insurance, Pharmaceutical Services Insurance providing for payment of services rendered by the pharmacist. Services include the preparation and distribution of medical products. Drug Benefit Plans,Drug Insurance,Prescription Insurance,Insurance, Pharmaceutic Services,Insurance, Pharmacy Services,Pharmaceutic Services Insurance,Pharmaceutical Services Insurance,Pharmacy Services Insurance,Drug Benefit Plan,Insurance, Drug,Insurance, Prescription,Plan, Drug Benefit,Plans, Drug Benefit
D011307 Drug Prescriptions Directions written for the obtaining and use of DRUGS. Drug Prescribing,Drug Prescription,Drug Prescribings,Prescribing, Drug,Prescribings, Drug
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003362 Cost-Benefit Analysis A method of comparing the cost of a program with its expected benefits in dollars (or other currency). The benefit-to-cost ratio is a measure of total return expected per unit of money spent. This analysis generally excludes consideration of factors that are not measured ultimately in economic terms. In contrast a cost effectiveness in general compares cost with qualitative outcomes. Cost and Benefit,Cost-Benefit Data,Benefits and Costs,Cost Benefit,Cost Benefit Analysis,Cost-Utility Analysis,Costs and Benefits,Economic Evaluation,Marginal Analysis,Analyses, Cost Benefit,Analysis, Cost Benefit,Analysis, Cost-Benefit,Analysis, Cost-Utility,Analysis, Marginal,Benefit and Cost,Cost Benefit Analyses,Cost Benefit Data,Cost Utility Analysis,Cost-Benefit Analyses,Cost-Utility Analyses,Data, Cost-Benefit,Economic Evaluations,Evaluation, Economic,Marginal Analyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001249 Asthma A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL). Asthma, Bronchial,Bronchial Asthma,Asthmas
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D012426 Russia A country located in north Asia bordering the Arctic Ocean, extending from Europe (the portion west of the Urals) to the North Pacific Ocean. The capital is Moscow. Russian S.F.S.R.,Russian Federation (Europe),Russian SFSR
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes

Related Publications

S L Leont'ev, and V G Mikhaĭlov, and V P Nevzorova, and R V Sadovnikova, and A F Shabashov, and T K Lugovkina, and I V Leshchenko, and E K Bel'tiukov, and M K Lebedeva
January 1973, Timarit Hjukrunarfelags Islands,
S L Leont'ev, and V G Mikhaĭlov, and V P Nevzorova, and R V Sadovnikova, and A F Shabashov, and T K Lugovkina, and I V Leshchenko, and E K Bel'tiukov, and M K Lebedeva
January 1986, Panminerva medica,
S L Leont'ev, and V G Mikhaĭlov, and V P Nevzorova, and R V Sadovnikova, and A F Shabashov, and T K Lugovkina, and I V Leshchenko, and E K Bel'tiukov, and M K Lebedeva
May 2006, Arerugi = [Allergy],
S L Leont'ev, and V G Mikhaĭlov, and V P Nevzorova, and R V Sadovnikova, and A F Shabashov, and T K Lugovkina, and I V Leshchenko, and E K Bel'tiukov, and M K Lebedeva
January 1991, Respiration; international review of thoracic diseases,
S L Leont'ev, and V G Mikhaĭlov, and V P Nevzorova, and R V Sadovnikova, and A F Shabashov, and T K Lugovkina, and I V Leshchenko, and E K Bel'tiukov, and M K Lebedeva
July 1952, The New England journal of medicine,
S L Leont'ev, and V G Mikhaĭlov, and V P Nevzorova, and R V Sadovnikova, and A F Shabashov, and T K Lugovkina, and I V Leshchenko, and E K Bel'tiukov, and M K Lebedeva
May 1990, The Medical clinics of North America,
S L Leont'ev, and V G Mikhaĭlov, and V P Nevzorova, and R V Sadovnikova, and A F Shabashov, and T K Lugovkina, and I V Leshchenko, and E K Bel'tiukov, and M K Lebedeva
July 1968, Naika. Internal medicine,
S L Leont'ev, and V G Mikhaĭlov, and V P Nevzorova, and R V Sadovnikova, and A F Shabashov, and T K Lugovkina, and I V Leshchenko, and E K Bel'tiukov, and M K Lebedeva
September 1978, Archives of internal medicine,
S L Leont'ev, and V G Mikhaĭlov, and V P Nevzorova, and R V Sadovnikova, and A F Shabashov, and T K Lugovkina, and I V Leshchenko, and E K Bel'tiukov, and M K Lebedeva
January 1977, The Journal of asthma research,
S L Leont'ev, and V G Mikhaĭlov, and V P Nevzorova, and R V Sadovnikova, and A F Shabashov, and T K Lugovkina, and I V Leshchenko, and E K Bel'tiukov, and M K Lebedeva
September 1949, Canadian Medical Association journal,
Copied contents to your clipboard!